Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults
Launched by UNIVERSITY OF REGINA · May 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how taking a creatine supplement might help improve strength and muscle growth in young people who are already physically active and doing resistance training, like lifting weights. Creatine is a substance that can enhance muscle performance, but the researchers want to find out the best way to take it for the greatest benefits.
To participate in this study, you need to be between 18 and 39 years old and should have been doing structured resistance training at least twice a week for the past month. Unfortunately, if you’re pregnant, nursing, have taken creatine in the last 30 days, or have an allergy to the placebo used in the trial, you won’t be able to join. If you do take part, you can expect to follow a training program while either taking the creatine or a placebo (a harmless substitute that looks like the real thing) to see how it affects your strength and muscle growth. This study is currently recruiting participants, so it’s a great chance to contribute to important research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Physically active (performing structured resistance training \> 2x/week for ≥ 4 weeks)
- • Males and females (age 18-39)
- Exclusion Criteria:
- • Pregnant or nursing
- • Have consumed creatine monohydrate within 30 days prior to the start of the study
- • Pre-existing allergies to the placebo
About University Of Regina
The University of Regina, a prominent Canadian institution known for its commitment to academic excellence and research innovation, serves as a clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a focus on interdisciplinary collaboration, the university leverages its diverse expertise to conduct clinical trials that address pressing health challenges and contribute to evidence-based practices. By fostering partnerships with healthcare professionals and community stakeholders, the University of Regina aims to enhance patient outcomes and promote public health through cutting-edge research and ethical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Regina, Saskatchewan, Canada
Patients applied
Trial Officials
Darren Candow
Principal Investigator
University of Regina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported